EURK:NASDAQEureka Acquisition Corp Analysis
Data as of 2026-07-10 - not real-time
$12.44
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Eureka Acquisition Corp is trading at $12.44, comfortably above its 20‑day SMA (≈$11.67) and 50‑day SMA (≈$11.53), indicating a short‑term bullish bias. The MACD shows a bullish signal with the line above the signal, while the RSI sits near 74, placing the stock in overbought territory and suggesting a potential pull‑back. Volume has been decreasing and the 30‑day volatility is high at over 23%, which amplifies short‑term price swings. The beta is essentially neutral (≈‑0.02), meaning market moves have little impact, but the thin trading volume and small market cap (~$27 M) create liquidity risk. Fundamentally, the company reports zero revenue, negative book value (P/B ≈‑29), and a sizable debt load of $1.9 B against modest cash of $0.15 M, making the current price appear disconnected from underlying assets. The recent announcement of a dividend from “excess cash” is not sustainable given the negative cash flows and high debt. Overall, technicals suggest a short‑term rally may be exhausted, while the lack of operating performance and deteriorating fundamentals point to a bearish longer‑term outlook.
Investors should weigh the speculative nature of a shell‑company SPAC, the overbought technical condition, and the unsustainable dividend claim before deciding on exposure.
Investors should weigh the speculative nature of a shell‑company SPAC, the overbought technical condition, and the unsustainable dividend claim before deciding on exposure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- RSI in overbought zone
- Decreasing volume trend
- Proximity to resistance at $14.28
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD but weak fundamentals
- Neutral beta limiting market‑driven moves
- Uncertain outcome of any merger or business combination
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Zero revenue and negative book value
- High debt relative to cash
- Unsustainable dividend claim
Key Metrics & Analysis
Financial Health
ROA-1.43%
P/B Ratio-29.1
Op. Cash Flow$-753140
Free Cash Flow$-354844
Industry P/E17.6
Technical Analysis
TrendBullish
RSI74.0
Support$11.06
Resistance$14.28
MA 20$11.67
MA 50$11.53
MA 200$11.15
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.02
Volatility23.47%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.